Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Pancreatic Neoplasms 58Carcinoma, Non-Small-Cell Lung 36Urinary Bladder Neoplasms 33Neoplasm Metastasis 20Lung Neoplasms 20Ovarian Neoplasms 19Lymphoma, Large B-Cell, Diffuse 18Cholangiocarcinoma 15Neoplasms 14Nasopharyngeal Carcinoma 14Biliary Tract Neoplasms 14Triple Negative Breast Neoplasms 13Colorectal Neoplasms 12Breast Neoplasms 12Carcinoma, Transitional Cell 11Non-Muscle Invasive Bladder Neoplasms 10Fallopian Tube Neoplasms 10Recurrence 9Gallbladder Neoplasms 8Sarcoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Bile Duct Neoplasms 6Uterine Cervical Neoplasms 5Osteosarcoma 5Lymphoma, Non-Hodgkin 5Lymphoma 5Hodgkin Disease 5Endometrial Neoplasms 5Melanoma 4Gastrointestinal Neoplasms 4

Interventions

Cisplatin 6Platinum 5Pemetrexed 51,2-diaminocyclohexaneplatinum II citrate 5pembrolizumab 4atezolizumab 2Radiotherapy 2Radiation 2Nivolumab 2Ipilimumab 2Gemcitabine 2Cyclophosphamide 2Carboplatin 2tremelimumab 1methoxyamine 1fludarabine 1decitabine and cedazuridine drug combination 1cediranib 1anetumab ravtansine 1aldesleukin 1Trioxsalen 1Tissue Banks 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Phototherapy 1Photochemotherapy 1Pharmacogenomic Testing 1Pharmaceutical Preparations 1Interleukin-2 1Influenza Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Gemcitabine × 90 days × Clear all
NCT03710876 2026-04-21

INFINITE

Ferring Ventures Limited

Phase 3 Completed
53 enrolled 23 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT04491942 2026-04-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
74 enrolled
BreastGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Penile Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡